Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1968 Aug;47(8):1843–1850. doi: 10.1172/JCI105874

Effect of dibutyryl cyclic adenosine 3′,5′-monophosphate, theophylline, and other nucleotides upon calcium and phosphate metabolism

Howard Rasmussen 1,2, Maurice Pechet 1,2, Danuta Fast 1,2
PMCID: PMC297344  PMID: 4299012

Abstract

The effect of dibutyryl cyclic adenosine 3′,5′-monophosphate upon calcium and phosphate metabolism in thyroparathyroidectomized rats was undertaken in an effort to clarify the possible role of adenosine 3′,5′-monophosphate (3′,5′ AMP) in parathyroid hormone action. The infusion of dibutyryl cyclic 3′,5′ AMP at a rate of 3 mg/hr into thyroparathyroidectomized rats leads to changes in calcium, phosphate, and hydroxyproline excretion, and calcium and phosphate concentrations in plasma that are qualitatively similar to those induced by parathyroid hormone given at a rate of 5 μg/hr. The effect of dibutyryl cyclic 3′,5′ AMP upon calcium and hydroxyproline mobilization from bone is blocked by thyrocalcitonin administration in the same way that thyrocalcitonin blocks PTH effects. Other closely related nucleotides do not act in the same way.

These data indicate that dibutyryl cyclic 3′,5′ AMP produces effects similar to parathyroid hormone in thyroparathyroidectomized rats, and support the notion that 3′,5′ AMP is an intermediate in the mechanism of PTH action. However, the changes in magnesium and potassium excretion are different after dibutyryl cyclic 3′,5′ AMP infusion from those seen after PTH infusion. Also, theophylline was found to potentiate the action of smaller doses of dibutyryl 3′,5′ AMP, but not that of PTH.

Full text

PDF
1845

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anast C., Arnaud C. D., Rasmussen H., Tenenhouse A. Thyrocalcitonin and the response to parathyroid hormone. J Clin Invest. 1967 Jan;46(1):57–64. doi: 10.1172/JCI105511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnaud C. D., Jr, Tenenhouse A. M., Rasmussen H. Parathyroid hormone. Annu Rev Physiol. 1967;29:349–372. doi: 10.1146/annurev.ph.29.030167.002025. [DOI] [PubMed] [Google Scholar]
  3. Arnaud C., Rasmussen H., Anast C. Further studies on the interrelationship between parathyroid hormone and vitamin D. J Clin Invest. 1966 Dec;45(12):1955–1964. doi: 10.1172/JCI105500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chase L. R., Aurbach G. D. Parathyroid function and the renal excretion of 3'5'-adenylic acid. Proc Natl Acad Sci U S A. 1967 Aug;58(2):518–525. doi: 10.1073/pnas.58.2.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chase L. R., Aurbach G. D. Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science. 1968 Feb 2;159(3814):545–547. doi: 10.1126/science.159.3814.545. [DOI] [PubMed] [Google Scholar]
  6. Grahame-Smith D. G., Butcher R. W., Ney R. L., Sutherland E. W. Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex. J Biol Chem. 1967 Dec 10;242(23):5535–5541. [PubMed] [Google Scholar]
  7. Gulyassy P. F., Edelman I. S. Effect of pH and theophylline on uptake, elution, and antidiuretic action of cyclic AMP. Am J Physiol. 1967 Apr;212(4):740–746. doi: 10.1152/ajplegacy.1967.212.4.740. [DOI] [PubMed] [Google Scholar]
  8. HAYNES R. C., Jr, SUTHERLAND E. W., RALL T. W. The role of cyclic adenylic acid in hormone action. Recent Prog Horm Res. 1960;16:121–138. [PubMed] [Google Scholar]
  9. Hawker C. D., Glass J. D., Rasmussen H. Further studies on the isolation and charcterization of parathyroid polypeptides. Biochemistry. 1966 Jan;5(1):344–352. doi: 10.1021/bi00865a044. [DOI] [PubMed] [Google Scholar]
  10. Hawker C. D., Rasmussen H., Glass J. Progress on the isolation of porcine thyrocalcitonin. Am J Med. 1967 Nov;43(5):656–661. doi: 10.1016/0002-9343(67)90106-4. [DOI] [PubMed] [Google Scholar]
  11. ORLOFF J., HANDLER J. S. The similarity of effects of vasopressin, adenosine-3',5'-phosphate (cyclic AMP) and theophylline on the toad bladder. J Clin Invest. 1962 Apr;41:702–709. doi: 10.1172/JCI104528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. POSTERNAK T., SUTHERLAND E. W., HENION W. F. Derivatives of cyclic 3',5'-adenosine monophosphate. Biochim Biophys Acta. 1962 Dec 17;65:558–560. doi: 10.1016/0006-3002(62)90475-4. [DOI] [PubMed] [Google Scholar]
  13. PROCKOP D. J., UDENFRIEND S. A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem. 1960 Nov;1:228–239. doi: 10.1016/0003-2697(60)90050-6. [DOI] [PubMed] [Google Scholar]
  14. Pastan I., Macchia V. Mechanism of thyroid-stimulating hormone action. Studies with dibutyl 3',5'-adenosine monophosphate and lecithinase C. J Biol Chem. 1967 Dec 25;242(24):5757–5761. [PubMed] [Google Scholar]
  15. Rasmussen H., Anast C., Arnaud C. Thyrocalcitonin, EGTA, and urinary electrolyte excretion. J Clin Invest. 1967 May;46(5):746–752. doi: 10.1172/JCI105575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SUTHERLAND E. W., OYE I., BUTCHER R. W. THE ACTION OF EPINEPHRINE AND THE ROLE OF THE ADENYL CYCLASE SYSTEM IN HORMONE ACTION. Recent Prog Horm Res. 1965;21:623–646. [PubMed] [Google Scholar]
  17. Szego C. M., Davis J. S. Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci U S A. 1967 Oct;58(4):1711–1718. doi: 10.1073/pnas.58.4.1711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wells H., Lloyd W. Effects of theophylline on the serum calcium of rats after parathyroidectomy and administration of parathyroid hormone. Endocrinology. 1967 Jul;81(1):139–144. doi: 10.1210/endo-81-1-139. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES